Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects the somatic motor system through the degeneration of upper and lower motors neurons. Evidence suggests that the cerebrospinal fluid (CSF), which is in direct contact with the nervous system, has soluble substance that could cause injuries in motor neurons. Animal models that express mutant ALS associated genes have been created to study the various etiopathological mechanisms which manifest themselves similarly to that occur in ALS patients. However, these models best represent the etiology of the disease in familiar cases and there is not yet an animal model that represents the characteristics of the disease in sporadic form, despite the similarity between familiar and sporadic cases. Thus, the aim of this study was to evaluate the motor and histological changes after intracerebroventricular injection (i.c.v.) of CSF from ALS sporadic patients in rats. 43 seven-month-old Wistar rats were used, coming from the sectoral animal facility of the Department of Physiology at the Federal University of Sergipe. The study was divided into two experiments: (I) with a single administration i.c.v. of the CSF and (II) with repeated administration i.c.v. of the CSF. In the experiment I, the animals were divided into 3 groups: control (CTR, artificial CSF solution), non-ALS (N-ALS, CSF of patients without neurological disease) and ALS (ALS, LCR of patients with sporadic ALS) who received a single injection i.c.v. (7.5μL) and one week after were subjected to motor tests: strength test, catalepsy test, open field test and walking test once a week for 30 days. In the Experiment II, animals were divided into 3 groups: control (CTR) Non-ALS (N-ALS) and ALS and they received daily injection for 6 days, i.c.v. (5.0μL). Throughout the treatment the animals underwent the motor tests already mentioned. After the tests, in both experiments, rats were anesthetized, perfused, their spinal cords were removed and subjected to histological analysis by hematoxylin-eosin for general morphological observation. In the first experiment ,in ALS group, motor alteration was observed in the strength test, open field and in the walking test, accompanied by a reduction of motor neurons and glial cells in the thoracic and lumbar regions of the spinal cord. In the second experiment, Also in the ALS group, it was observed driving change in catalepsy, open field and in the walking test, accompanied by an increase of glial cells in the lumbar region of the spinal cord. Data presented in this study show that the CSF management of ALS patients can cause pathogenic mechanisms similar to those seen in humans and other animal models of ALS. / A Esclerose Lateral Amiotrófica (ELA) é uma doença neurodegenerativa progressiva, que afeta o sistema motor somático através da degeneração dos neurônios motores superiores e inferiores. Evidências apontam que o líquido cefalorraquidiano (LCR), que está em íntimo contato com o sistema nervoso, apresenta substâncias solúveis que podem provocar lesões em neurônios motores. Modelos animais que expressam genes mutantes associados à ELA foram desenvolvidos, para o estudo dos mais diversos mecanismos etiopatológicos que se manifestam de forma similar aos que ocorrem em pacientes com a doença. Entretanto, esses modelos representam melhor a etiologia da doença em casos familiares e, apesar da semelhança entre casos familiares e esporádicos, ainda não se tem um modelo animal que represente características da doença nesta última. Diante disso, o objetivo do presente trabalho foi avaliar as alterações motoras e histológicas após injeção intracerebroventricular (i.c.v.) de LCR de pacientes com ELA esporádica em ratos Wistar. Foram ultilizados 43 ratos Wistar, com idade aproximada de sete meses, provenientes do Biotério Setorial do Departamento de Fisiologia da Universidade Federal de Sergipe. O trabalho foi dividido em 2 experimentos: (I) com uma única administração i.c.v. de LCR e (II) com administrações repetidas i.c.v. de LCR. No experimento I os animais foram divididos em 3 grupos, controle (CTR, solução de LCR artificial), não-ELA (NELA, LCR de pacientes sem doenças neurológicas) e ELA (ELA, LCR de paciente com ELA esporádica) que receberam uma única injeção i.c.v. de 7,5 μL e após uma semana foram submetidos aos testes motores: teste de força, catalepsia, campo aberto e teste de marcha uma vez por semana durante 30 dias. No experimento II, os animais foram divididos em 3 grupos, controle (CTR), Não-ELA (N-ELA) e ELA que receberam uma injeção diária, durante 6 dias, i.c.v. de 5 μL. Ao longo do tratamento, os animais foram submetidos aos testes motores acima mencionados. Após os testes, em ambos experimentos, os ratos foram anestesiados, perfundidos, suas medulas removidas e submetidas à análise histológica pela coloração de hematoxilina-eosina para observação morfológica geral. No experimento I, no grupo ELA, foi observado alteração motora no teste de força, campo aberto e no teste de marcha, acompanhado por uma redução de neurônios motores e células gliais na região torácica e lombar da medula espinal. No experimento II, também no grupo ELA, foi observado alteração motora na catalepsia, campo aberto e no teste de marcha, acompanhado de um aumento de células gliais na região lombar da medula espinal. Os dados apresentados neste estudo mostram que a administração de LCR de pacientes com ELA pode provocar mecanismos patogênicos semelhantes aos observados em humanos e outros modelos animais de ELA.

A artroscopia e a artrocentese são procedimentos considerados minimamente invasivos utilizados para o tratamento das disfunções temporomandibulares (DTM) e são métodos considerados intermediários entre a terapia conservadora e a cirurgia aberta da articulação temporomandibular (ATM). Apresentam como vantagem, em relação a cirurgia aberta, a pequena morbidade e o breve tempo de recuperação necessária aos pacientes. Desde o início do desenvolvimento da artroscopia esteve presente a preocupação com a possibilidade de danos a estruturas internas da ATM, com essa finalidade vários estudos em animais foram desenvolvidos evidenciando que realmente podem ocorrer lesões iatrogênicas as estruturas internas desencadeando processo degenerativo na articulação. A avaliação do mesmo potencial de lesão para artrocentese não existe, assim o objetivo deste trabalho foi avaliar o trauma operatório da artrocentese comparativamente a artroscopia aos tecidos da ATM em suínos. Realizou-se experimento em vinte ATM de dez cabeças de suínos sendo seis artroscopias; seis artrocenteses e oito ATM utilizadas como controle. Após a realização dos procedimentos as ATM foram cuidadosamente dissecadas, examinadas e fotografadas com registro de alterações traumáticas ao disco articular e as fibrocartilagens da fossa articular e da cabeça da mandíbula. As imagens das estruturas foram analisadas por outro examinador que não tinha conhecimento prévio de qual procedimento havia sido realizado em cada ATM classificando as lesões de acordo com o número e localidade em: ausente (sem alteração visível); leve (descolamento de fibrocartilagem da fossa ou cabeça da mandíbula isoladas e únicas), moderado (perfurações do disco e mais de um descolamento de fibrocartilagem da fossa ou cabeça da mandíbula) e severo (lacerações do disco e lesões múltiplas em mais de uma estrutura). Os dados também foram classificados em ausente e presente para uma comparação direta. Foi realizada análise estatística dos dados. No grupo controle ocorreram danos em duas das oito ATM durante a dissecção, que apresentaram características distintas das lesões constatadas após os procedimentos, nas outras seis nenhuma alteração traumática pode ser evidenciada. No grupo submetido a artrocentese os danos foram ausentes, leves e moderados em 16.7% respectivamente e severos em 50% da amostra. No grupo submetido a artroscopia ocorreram danos moderados em 66.7%, severos em 16.7%, ausentes em 16.7% e não ocorreram danos leves. Em ambos os grupos foram evidenciadas a presença de lesões em 83.3% das amostras. Apesar de não haver diferença estatisticamente significativa entre os danos verificados, em uma análise direta, a severidade das lesões constatadas após artrocentese foi maior. Conclui-se que a artrocentese e a artroscopia não são isentas de morbidade aos tecidos articulares e independentemente de serem procedimentos considerados minimamente invasivos não se pode desprezar o potencial de danos as superfícies articulares. / Arthroscopy and arthrocentesis are considered minimally invasive procedures for the treatment of temporomandibular disorders (TMD) and are situated between conservative therapies and open surgery of the temporomandibular joint (TMJ). When compared to open surgery they present the advantages of having a brief post operatory recovery time for the patient and little morbidity. Since the beginning of the development of arthroscopy the possibility of damage to the inner structures of the TMJ was a concern, as a result a series of studies in animals were made and it became clear that iatrogenic damage can really happen and trigger degenerative alterations in the joint. Considering that there are no studies that investigate the potential of causing structural damage to the TMJ during arthrocentesis the objective of this study was to evaluate the operative trauma of arthroscopy and arthrocentesis to the tissues of the TMJ using swine heads. Twenty TMJ of ten swine heads were used for six arthroscopies; six arthrocentesis and eight that were used as a control group. After the procedures the TMJ were carefully dissected, examined and photographed. Traumatic alterations to the articular disk and to the fossa and head of the mandible fibrocartilage were recorded. The images of the structures were analyzed by other examiner that did not had previous knowledge of witch procedure each TMJ was subjected to. The lesions that were identified were classified according to the location and number as: absent (no visible alteration); light (one isolated scuffing of the fibrocartilage of the fossa or the head of the mandible); moderate (disk perforation or multiple scuffing of the fibrocartilage of the fossa or head of the mandible) and severe (disk laceration or multiple lesions in more than one structure). The obtained data was also classified as absent or present for a direct comparison. Statistical analyses of the obtained data were made. In the control group damage to two of the eight TMJ was perceived during dissection, the characteristics of those lesions were clearly different from those observed after the procedures, in the other six none traumatic damage could be noticed. In the arthrocentesis group the damages were absent, light and moderate in 16.7% respectively and were severe in 50% of the sample. In the arthroscopy group damage was moderate in 66.7%, severe in 16.7%, absent in 16.7 and no light damage occurred. In both groups damage was present in 83.3% of the sample. Even though the difference between the groups was not statistically significant, making a direct analysis of the data, the severity of the lesions found in the arthrocentesis group was higher. It was concluded that arthrocentesis and arthroscopy are not absent of morbidity to the TMJ tissues and regarded of being minimally invasive procedures the potential of damage to the structures of the TMJ should not be minimized.

La maladie d'Alzheimer (MA) est caractérisée par un déclin progressif des fonctions cognitives avec une détérioration de la mémoire, une atrophie cérébrale et deux lésions histologiques caractéristiques retrouvées lors d'examens post-mortem : les plaques extracellulaires de peptide β-amyloïde et les enchevêtrements intracellulaires de la protéine Tau anormalement phosphorylée. De nombreux modèles animaux de la MA ont été développés afin de comprendre et de tester différents traitements dirigés contre cette pathologie. Cependant, aucun modèle de rongeur non transgénique, développant à la fois les plaques amyloïdes et la pathologie neurofibrillaire, n'est disponible à ce jour. L'objectif de cette étude est de développer le premier modèle non transgénique, développant les deux lésions histologiques caractéristiques de la MA chez le rat. Le principe consiste à réaliser une injection concomitante et intrahippocampale d'un AAV (virus associé aux adénovirus) recombinant contenant le gène humain de la protéine Tau présentant la mutation P301L, et du peptide Aβ1-42 qui est le principal composant des plaques amyloïdes. Après plusieurs expériences, nous avons obtenu un modèle animal représentatif des stades précoces de la MA, c'est-à-dire avec des lésions focalisées dans l'une des premières structures du cerveau affectée par la MA : l'hippocampe. La présence des deux lésions histopathologiques caractéristiques de la maladie, accompagnée d'une astrocytose, a été observée par immunohistofluorescence. Une détérioration de la mémoire concernant plus particulièrement la mémoire de travail, ainsi que des anormalités de l'activité électrique cérébrale et notamment durant les phases de sommeil paradoxal, enregistrées par électroencéphalographie, ont également été mises en évidence. / Alzheimer's disease (AD) is characterized by a progressive decline in cognitive function with a memory impairment, a brain atrophy, and two histological hallmarks observed from post-mortem examination: extracellular β-amyloid plaques and intracellular tangles of the Tau protein abnormally phosphorylated. Numerous animal models of AD have been developed to understand and to test drugs against this pathology. However, any non-transgenic model of rodent developing amyloid plaques and the neurofibrilary pathology is currently available. The aim of this study is to develop the first non-transgenic model producing the two histopathological features of AD in the rat. The principle is to perform a concomitant intrahippocampal injection of a recombinant AAV (Adeno-Associated Virus) containing the human transgene tau with the P301L mutation, and of Aβ1-42 peptide, the main component of the amyloid plaques. After several experiments, we have obtained an animal model representative of the early steps of AD, i.e. with lesions focalized in one of the first affected brain structures in the AD: the hippocampus. The presence of the two histopathological hallmarks has been observed by immunohistofluorescence and associated with an astrogliosis. A memory impairment concerning more particulary the working memory, and abnormalities of the electrical activity of the brain and of the rapid eye movement sleep recorded by electroencephalography, are also characterized.

The fever response, besides being part of host defense response to infection or inflammation, is associated with discomfort and anxiety and may constitute a risk for febrile seizures in children. Therefore, antipyretic therapy is routinely prescribed for febrile patients. The animal models of fever using the systemic injection of lipopolysaccharide (LPS) and Baker yeast, described in the literature, are suitable for screening of novel antipyretics, but they do not provide information regarding the mechanism of action of these compounds. Therefore, the present study aimed to describe and validate a model of fever induction by prostaglandin (PG) E2, the final mediator of febrile response in the central nervous system, in young male Wistar rats (25-30 days of age). In this protocol, PGE2 was injected intrathecally without implantation of cannula. Rectal temperature (TR) was recorded every thirty minutes for three hours after PGE2 injection (08:00 11:00 h). The intrathecal (i.t.) injection of PGE2 10 ηg in 100 μL/animal induced fever in the animals, which was prevented by administration of EP1 and EP3 receptors antagonists, but did not by antagonist of EP4 receptor. In addition, the classic antipyretics dipyrone and acetaminophen, at doses that had no effect per se on TR of animals, did not revert the fever induced by i.t. injection of PGE2. This model seems suitable to investigate whether the action of antipyretics occurs upstream or downstream the prostaglandin coupling in EP receptors. In addition, this protocol is advantageous from the technical, ethical and economical point of view compared to others PGE2-induced fever protocols described in the literature, because trepanation for cannula implantation is not required, reducing the inflammatory response, animals suffering and experimental costs. / A febre, apesar de fazer parte da resposta de defesa do hospedeiro à infecção ou inflamação, está associada com desconforto e ansiedade, além de representar um risco iminente de convulsões febris em crianças. Por isso, terapia antipirética é rotineiramente prescrita a pacientes febris. Os modelos animais de febre empregando a injeção sistêmica de lipopolissacarídeo (LPS) e fermento de padeiro, descritos na literatura, são úteis para a triagem de novos antipiréticos, mas não fornecem informações a respeito do mecanismo de ação desses compostos. Diante disso, o presente estudo objetivou padronizar e validar um modelo de indução de febre por prostaglandina (PG) E2, o mediador final da resposta febril no sistema nervoso central, em ratos machos jovens da raça Wistar (25-30 dias). Neste protocolo, a PGE2 foi injetada pela via intratecal (i.t.), não necessitando a implantação de cânula. A temperatura retal (TR) foi registrada a cada trinta minutos durante três horas após a injeção da PGE2 (08:00-11:00 h). A injeção i.t. de PGE2 10 ηg em 100 μL/animal induziu febre nos animais, a qual foi prevenida pela administração de antagonistas dos receptores EP1 e EP3, mas não por antagonista do receptor EP4. Além disso, os antipiréticos clássicos dipirona e paracetamol, em doses que não tiveram efeito per se na TR dos animais, não reverteram a febre induzida por PGE2 i.t. Este modelo parece útil para investigar se a ação dos antipiréticos ocorre antes ou depois da ligação da PGE2 em seus receptores EP. Além disso, este protocolo é vantajoso do ponto de vista técnico, ético e econômico em relação aos outros protocolos de indução de febre por PGE2 descritos na literatura, porque a trepanação para implantação de cânula não é necessária, reduzindo a resposta inflamatória, o sofrimento dos animais e os custos experimentais.

L'hépatite C (VHC) est l'une des causes principales de maladies du foie dans le monde, qui représentent un risque élevé d'évoluer vers la cirrhose et le carcinome hépatocellulaire. Actuellement, le traitement standard de l’infection par le VHC est l'interféron pégylé-(peg-IFN) et la ribavirine. Bien que le taux de la réponse virale soutenue (RVS) au traitement se soit améliorée au cours de ces années, cette thérapie n'est pas efficace chez tous les patients. En outre, plusieurs effets secondaires toxiques, de complications et le coût élevé limitent la compliance du patient et l'efficacité du traitement. Il n'existe pas de modèle simple d'infection par le VHC et il est nécessaire de développer des modèles in vitro et in vivo utiles pour étudier la physiopathologie de l'infection par le VHC, y compris les événements précoces de l'infection aiguë (l'entrée du virus, des mécanismes immunologiques et génétiques prédictifs) ainsi que l'évaluation de la puissance des médicaments antiviraux contre le VHC. Nous rapportons ici, nos efforts visant à développer des modèles appropriés de l'infection par le VHC. Dans un premier temps, nous avons établi un modèle de petit animal pour étudier l'infection par le VHC. Tupaia est un petit animal, apparenté aux primates et peu couteux. Dans notre travail, nous avons étudié la susceptibilité du tupaia à l'infection par VHC. Douze tupaias adultes ont été inoculés avec le VHC provenant de sérum de patient et d'ARN du VHC (génotype 1a). Trois jeunes tupaias ont été artificiellement nourris pendant un mois et ensuite inoculés par le VHC provenant de sérum du patient. L'ARN du VHC, les anticorps anti-VHC et l’évolution des quasi-espèces du VHC ont été déterminées chez l'animal avant et après l'inoculation. L'infection transitoire et intermittente s'est produite chez deux des 3 jeunes tupaias et l’infection chronique par le VHC s’est produite chez quatre tupaias sur 12 tupaias adultes. Le tupaia devrait représenter un modèle utile pour l'étude de l’infection chronique par le VHC. Dans une deuxième étape, un système de culture in vitro d'hépatocytes primaires de Tupaia a été établi, dans lequel l'infection par le VHC ne pouvait être bloquée ni par le CD81 soluble ni par des anticorps dirigés contre le CD81. Pour comprendre ces résultats, nous avons cloné, séquencé la grande boucle extracellulaire (LEL) du CD81 chez le Tupaia et analysé l'interaction de la protéine d’enveloppe E2 du VHC avec la LEL du CD81 chez le Tupaia par un test « enzyme-linked immunosorbent assay » (EIA). Nous avons constaté que chez le Tupaia, la séquence d'acides aminés du LEL de CD81 qui se lie au VHC présentait en 6 résidus d'acides aminés différents par rapport à la séquence humaine et la capacité de LEL de CD81 à se lier à la proteine d’enveloppe E2 du VHC a également diminuée. La structure différente de CD81 chez l’homme et chez le tupaia pourrait expliquer l'altération de l'interaction entre CD81 et la proteine E2 du VHC. Ce résultat démontre un rôle important de LEL du CD81 pour l'entrée du VHC. Dans une troisième étape, nous avons développé un modèle ex vivo de culture de tranches de foie humain et leur infection par le VHC. Le développement de lignées cellulaires provenant d’hepatocarcinome, permissives à la réplication du VHC, a fourni d'importants nouveaux outils virologiques pour étudier les mécanismes de l'infection par le VHC, mais ce modèle expérimental reste relativement éloigné des conditions physiologiques et pathologiques. Nous rapportons ici le développement d'un nouveau modèle ex vivo utilisant la culture de tranches de foie humain adulte, démontrant, pour la première fois, la capacité d’isolats primaires ainsi que JFH -1, H77/C3, Con1/C3 (HCVcc), de répliquer et de produire de novo des particules virales infectieuses ayant un titre viral élevé… / Hepatitis C virus (HCV) is one of the major causes of liver disease all over the world which has a high risk to progress to cirrhosis and hepatocellular carcinoma. Currently, the licensed standard treatment of HCV infection is Pegylated-interferon (peg-IFN) and ribavirin. Although the sustained viral response (SVR) rate of treatment has improved during these years, this therapy is not effective in all patients. In addition, several toxic side effects, complication and high cost limit the patient compliance and the efficacy of the treatment. There is no easy model of HCV infection and it is necessary to develop useful in vitro and in vivo models to study the pathobiology of HCV infection, including early events of acute infection (viral entry, immunological mechanisms, and genetic predictors) as well as the evaluation of the potency of the HCV antiviral drugs. We report here in our efforts in developing suitable models of HCV infection. In a first step, we preliminary established a small animal model to study HCV infection. Tupaia is a small, closed related to primate and cost-effective animal. In our work, we investigated the susceptibly of tupaia to HCV infection. Twelve adult tupaias were inoculated with native HCV from patient serum and full-length HCV RNA (Genotype 1a). Three young tupaias were artificially breeded for a month and then inoculated by native HCV from patient serum. HCV RNA, anti-HCV and HCV quasi species evolution were determined in the animal before and after inoculation. Transient and intermittent infection occurred in two among 3 young tupaias and HCV chronic infection occurred in four among 12 adult tupaias. Tupaia should represent a useful model for study HCV chronic infection. In a second step, an in vitro culture system of primary tupaia hepatocytes has been established in which HCV infection could be blocked neither by the soluble CD81 nor by antibodies against CD81. To understand these results, we cloned, sequenced the large extracellular loop (LEL) of tupaia CD81 and analyzed the interaction of HCV E2 with the tupaia CD81 LEL by enzyme-linked immunosorbent assay (EIA). We found that in the tupaia the amino acids sequence of HCV CD81 LEL presented in 6 different amino acid residues compared with human CD81 LEL sequence and the CD81 LEL ability to bind to HCV E2 was also decreased. The different structure of CD81 between human and tupaia could explain the alteration of the interaction between HCV E2 and CD81. This result demonstrated an important role of CD81 LEL for HCV entry. In a third step, we developed an ex vivo model of human liver slices culture and their infection with HCV. The development of human cultured HCV-replication-permissive hepatocarcinoma cell lines has provided important new virological tools to study the mechanisms of HCV infection; however this experimental model remains distantly related to physiological and pathological conditions. Here, we report the development of a new ex vivo model using human adult liver slices culture, demonstrating, for the first time, the ability of primary isolates to undergo de novo viral replication with the production of high titer infectious virus, as well as JFH-1, H77/C3, Con1/C3 (HCVcc). This experimental model was validated by demonstrating the HCV neutralization or HCV inhibition, in a dose-dependent manner, either by CD81 or E2 specific antibodies or convalescent serum from a recovered HCV patient, or by anti-viral drugs. This new ex vivo model represents a powerful tool for studying the viral life cycle, dynamics of virus spread in the liver and also for evaluating the efficacy of the new antiviral drugs. In the last step, we evaluated the efficacy of the new antiviral drugs with our ex vivo model of human adult liver slices. HCV NS3/4A protease is essential for viral replication and has been one of the most important target for developing specific antiviral drug

Le glioblastome (GBM) est la tumeur cérébrale primaire la plus fréquente et agressive chez l’adulte. Son traitement, une exérèse chirurgicale maximale suivi d’un traitement adjuvant (radiothérapie et témozolomide [TMZ]), n’offre qu’un bénéfice modeste de survie médiane (14.6 mois vs. 12.1 mois pour radiothérapie post-chirurgie seule) (STUPP et al., 2005). Le TMZ demeure l’agent de choix pour le traitement du GBM. Malgré sa biodisponibilité approchant 100% suivant son administration per os (PO) (Diez et al., 2009), sa pénétration dans le liquide céphalorachidien n’est que de 20% (Ostermann et al., 2004). Ainsi, il se peut que les limites thérapeutiques du TMZ soient reliées aux barrières hémato-encéphalique (BHE) et hémato-tumorale (BHT). Plusieurs stratégies alternatives tentent de contourner ces barrières comme l’administration intra-artérielle (IA) avec une ouverture osmotique de la BHE (OBHE). Cette technique permet une plus grande distribution d’agent thérapeutique au système nerveux central (SNC). L’utilisation de cette stratégie avec le témozolomide n’a jamais été étudiée à ce jour. Nous avons émis l’hypothèse que son utilisation permettra d’augmenter la concentration de TMZ dans le SNC et que, lorsque combiné avec la radiothérapie, permettra de rehausser son activité anti-tumorale. Les objectifs du projet sont : (1) l’évaluation de la sensibilité des cellules F98 au TMZ in vitro; (2) la caractérisation de la neuropharmacocinétique du TMZ in vivo, selon différents modes d’administration; et (3) l’évaluation de l’effet anti-tumoral du TMZ in vivo, selon différents modes d’administration. Les expérimentations in vivo ont été exécutées dans le modèle syngénique Fischer-F98, porteur de tumeur gliale. L’expérimentation in vitro a démontré une résistance importante des cellules F98 au TMZ. La méthodologie développée a permis de démontrer que l’infusion IA avec et sans OBHE augmente la concentration maximale et l’aire sous la courbe du TMZ dans la tumeur cérébrale et dans le parenchyme cérébral ipsilatéral du rat Fischer-F98. Par contre, aucun bénéfice de survie n’a été observé en utilisant ces stratégies alternatives. Au contraire, l’acheminement augmenté du TMZ au SNC semble toxique. Un bénéfice de survie a été mesuré suite à l’ajout d’un traitement de radiothérapie, mais de façon indépendante au mode de livraison de TMZ ou de solution saline normale (groupe contrôle). Enfin, nos résultats témoignent de l’impact du mode d’acheminement sur la distribution d’un agent thérapeutique au SNC. En détournant la BHE, l’utilisation judicieuse d’approches alternatives combinée à un agent thérapeutique approprié a un grand potentiel clinique dans le traitement des GBM. / Abstract : Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor in adults. Its’ standard treatment, maximal surgical resection followed by an adjuvant treatment (radiotherapy and temozolomide [TMZ]) offers only a modest median survival benefit of 14.6 months (vs. 12.1 months with post-surgery radiotherapy alone) (Stupp et al., 2005). TMZ remains the therapeutic agent of choice for the treatment of GBM. Despite its bioavailability approaching 100% after a per os administration (Diez et al., 2009), its cerebrospinal fluid penetration is only of 20% (Ostermann et al., 2004). Thus, TMZ’s therapeutic limitations could be due to the blood-brain barrier (BBB) and blood-tumor barrier (BTB). Alternative routes of drug delivery attempt to bypass these barriers. For example, intra-arterial (IA) administration with an osmotic blood-brain barrier disruption (OBBBD) allows greater drug distribution to the central nervous system (CNS). Its use with TMZ, with or without radiotherapy, has never been studied. We hypothesized that it will increase TMZ concentration in the CNS and that, when combined to radiotherapy, it will intensify its anti-neoplastic activity. The project was divided in three parts: (1) the evaluation of F98 cells’ in vitro sensitivity to TMZ; (2) the in vivo caracterization of TMZ’s neuropharmacokinetics, following different routes of administration; and (3) the in vivo evaluation of TMZ’s anti-tumoral effect, following different routes of administration. The syngenic glioma Fischer-F98 model was used in all in vivo experiments. Our results showed the F98 cells to be resistant to TMZ in vitro. The methodology developed showed that an IA infusion with and without OBBBD increased TMZ’s peak concentration and area under the curve in the brain tumor and ipsilateral brain parenchyma in the Fischer-F98 rat. All the while limiting systemic exposure. However, no survival benefit was observed with the use of these alternative strategies. More so, TMZ’s enhanced delivery to the CNS seemed toxic. A survival benefit was measured following the addition of radiotherapy. This was independent of the route of delivery of TMZ or normal saline. In summary, our results provide evidence that the method of TMZ administration does impact its CNS delivery. By bypassing the BBB, the judicious use of local delivery approaches combined with the appropriate therapeutic agent can have a great clinical potential in the treatment of glioblastomas.

Thoracic surgical procedures require partial or complete airway separation and the opportunity to exclude one lung from ventilation (one-lung ventilation, OLV). OLV is commonly associated with profound pathophysiological changes that may affect the postoperative outcome. It is injurious in terms of increased mechanical stress including alveolar cell stretch and overdistension, shear forces secondary to repeated tidal collapse and reopening of alveolar units and compression of alveolar vessels. Ventilation and perfusion distribution may thus be affected during and after OLV. The present studies investigated the influence of OLV on ventilation and perfusion distribution, on the gas/tissue distribution and on the lung histomorphology in a pig model of thoracic surgery. Anaesthetised and mechanically ventilated piglets were examined. The ventilation and perfusion distribution within the lungs was assessed by single photon emission computed tomography. Computed tomography was used to establish the effects of OLV on dependent lung gas/tissue distribution. The pulmonary histopathology of pigs undergoing OLV and thoracic surgery was compared with that of two-lung ventilation (TLV) and spontaneous breathing. OLV induced hyperperfusion and significant V/Q mismatch in the ventilated lung persistent in the postoperative course. It increased cyclic tidal recruitment that was associated with a persistent increase of gas content in the ventilated lung. OLV and thoracic surgery as well resulted in alveolar damage.  In the present model of OLV and thoracic surgery, alveolar recruitment manoeuvre (ARM) and protective ventilation approach using low tidal volume preserved the ventilated lung density distribution and did not aggravate cyclic recruitment of alveoli in the ventilated lung. In conclusion, the present model established significant alveolar damage in response to OLV and thoracic surgery. Lung injury could be related to the profound pathophysiological consequences of OLV including hyperperfusion, ventilation/perfusion mismatch and increased tidal recruitment of lung tissue in the dependent, ventilated lung.  These mechanisms may contribute to the increased susceptibility for respiratory complications in patients undergoing thoracic surgery. A protective approach including sufficient ARM, application of PEEP, and the use of lower tidal volumes may prevent the ventilated lung from deleterious consequences of OLV.

L'efficacité du rtPA dans le traitement de l’ischémie aigue est bien reconnue avec des effets secondaires graves nécessitant l’évaluation d’autres stratégies. Un modèle d’ischémie cérébrale focale a été décrit, réalisé par injection in situ de thrombine. Dans notre première étude, nous avons utilisé l’imagerie par résonance magnétique multimodale pour documenter les lésions et les zones de pénombre dans ce modèle. Malgré une occlusion de l’artère reproductible et une hypoperfusion marquée chez tous les sujets, une reperfusion spontanée est constatée dans 38% des cas, rendant l’IRM incontournable dans l’évaluation de ce modèle. La deuxième étude a comparé l'efficacité d’un TAFI inhibiteur seul ou en combinaison avec le rtPA à faible dose. Nous avons montré que la combinaison du TAFI inhibiteur avec le rtPA à faible dose n'est pas aussi efficace que la dose standard de rtPA, avec une tendance positive, tandis que le TAFI inhibiteur seul n'est pas efficace du tout. Le modèle thromboembolique présente un intérêt particulier dans l'évaluation des stratégies thérapeutiques associées au rtPA pour améliorer la thrombolyse, surtout lorsqu'il est évalué par un suivi longitudinal en IRM / The benefit of recombinant tissue plasminogen activator (rtPA) treatment in stroke is well known with serious side effects requiring the evaluation of alternative strategies. Injection of thrombin in the middle cerebral artery of mice has been proposed as a new model of thromboembolic stroke. In the first study, we used multiparametric Magnetic Resonance Imaging (MRI), performed immediately after thrombin injection, to document occlusion and area at risk in this model. Despite similar MCA occlusion and marked hypoperfusion, half of animals showed a cortical lesion on DWI, while the other half demonstrated no or very limited lesion. Therefore, MRI measurement of basal lesion size is required to use this animal model in therapeutic studies. The second study compared efficacy between TAFI inhibitor alone and TAFI inhibitor in combination with low-dose rtPA. In conclusion, we showed that the combination of TAFI-I with low-dose rtPA is not as effective as the standard dose of rtPA, with a positive trend, while TAFI inhibition alone is not effective at all. The present thromboembolic model is of particular interest in assessing strategies rtPA association to improve thrombolysis, especially when coupled with longitudinal MRI assessment

As técnicas sorológicas são os testes de referência para o diagnóstico da doença de Chagas, porém, são pouco efetivas para avaliar a resposta ao tratamento, uma vez que a soronegativação pode levar muitos anos. As sorologias também são usadas para identificar episódios de reativação em pacientes com algum grau de imunodeficiência, por exemplo, os co-infectados pelo HIV. Já a hemocultura e o xenodiagnóstico possuem elevada especificidade e baixa sensibilidade, requerendo de 30 a 120 dias para a liberação do resultado final, podendo gerar resultados falso-negativos especialmente na fase crônica da infecção. Diante disso, a PCR em tempo real (qPCR), técnica com elevada sensibilidade e especificidade, poderia ser utilizada para detectar e quantificar a carga parasitária, permitindo o diagnóstico de episódios de reativação e o monitoramento de pacientes em tratamento. A escolha dos alvos de amplificação e dos iniciadores da qPCR é desafiadora, já que ainda não existe consenso na literatura sobre a melhor sequência alvo de amplificação e os melhores iniciadores. No presente estudo, foram selecionados iniciadores do DNA nuclear (F2/B3) e do mitocondrial (32F/148R) de T. cruzi. Posteriormente, para validação dos ensaios, foram obtidas amostras de sangue, cérebro, coração, pulmão, fígado, baço, rim, intestino, glândulas adrenais, tecido adiposo e tecido muscular esquelético de 24 camundongos Swiss adultos, infectados intraperitonealmente com 103 formas tripomastigotas da cepa Y de Trypanosoma cruzi. Amostras foram colhidas no 13º, 26º e 61º dias pós-infecção, correspondendo a diferentes intensidades de carga parasitária (alta, média e baixa). As amostras foram analisadas por qPCR com SYBR Green. Os resultados mostraram que os iniciadores do DNA nuclear e mitocondrial detectaram T. cruzi de forma específica, sendo que as maiores cargas parasitárias foram detectadas pelos iniciadores do DNA nuclear, embora os iniciadores do DNA mitocondrial tenham apresentado maior sensibilidade analítica (0,002 e 0,0002 de um único parasito, respectivamente). As duas qPCR obtiveram índices adequados de reprodutibilidade e repetibilidade inferiores a 25%. Os parâmetros de eficiência, (90%- 110%) e linearidade (R2 >= 0.98) das duas qPCR apresentaram valores adequados de acordo com o estabelecido pela literatura especializada. A comparação do threshold cycle (CT) das duas qPCR não apresentou diferença estatística. Em relação à carga parasitária foi possível detectar o DNA do parasito em todas as amostras de sangue e tecidos, com distribuição universal, porém heterogênea, e em todas as fases da infecção. O modelo animal utilizado neste estudo foi adequado para validar as duas qPCR voltadas à detecção e quantificação da carga parasitária. De acordo com os parâmetros estabelecidos, as duas qPCR, com iniciadores do DNA nuclear e do mitocondrial, foram padronizadas e validadas com sucesso, sendo capazes de quantificar todos os tipos de amostras (sangue e órgãos), nas fases aguda, subaguda e crônica da doença, sinalizando positivamente para a utilização dos dois ensaios moleculares no diagnóstico da infecção por T. cruzi. / Serological techniques are the gold standards for the diagnosis of Chagas\' disease, but are not very effective in evaluating the response to treatment, since seronegativation may take many years. Serology is also used to identify reactivation episodes in patients with some degree of immunodeficiency, for example those co-infected with HIV. Hemoculture and xenodiagnosis have high specificity and low sensitivity, requiring 30 to 120 days for releasing a final result, and they can generate false-negative results especially in the chronic phase of infection. Therefore, real-time PCR (qPCR), a technique with high sensitivity and specificity, could be used to detect and quantify the parasite load, allowing the diagnosis of reactivation episodes and the monitoring of patients undergoing treatment. The choice of amplification targets and qPCR primers is challenging since there is as yet no consensus in the literature about the best amplification target sequence and the best primers. In the present study, primers from the nuclear (F2/B3) and mitochondrial, kDNA (32F/148R) T. cruzi sequences were designed. Samples were obtained from the blood, brain, heart, lung, liver, spleen, kidney, intestine, adrenal glands, adipose tissue and skeletal muscle tissue of 24 adult Swiss mice, infected intraperitoneally with 103 trypomastigote forms of the Y strain of Trypanosoma cruzi. The samples were collected at the 13th, 26th and 61st post-infection days, corresponding to different parasite load levels (low, medium and high), and were analyzed by qPCR with SYBR Green. The results showed that the nuclear and mitochondrial DNA primers detected T. cruzi DNA in a specific way. The nuclear primers detected higher parasite load levels than the kDNA ones, although the kDNA primers presented higher analytical sensitivity (0.002 and 0.0002 of a single parasite, respectively). The two qPCRs showed adequate reproducibility and repeatability indexes, i.e., below 25%. The efficiency parameters, (90% - 110%) and linearity (R2 >=0.98) of the two qPCRs showed adequate values according to the established literature. The comparison of the threshold cycle (CT) of the two qPCRs found no statistical difference. Regarding the parasite load, it was possible to detect the parasite DNA in all blood and tissue samples, with universal distribution, however heterogeneous, and at all stages of infection. The animal model used in this study was adequate to validate the two qPCRs for the detection and quantification of the parasite load. According to established parameters, the two qPCRs, with nuclear and mitochondrial primers, were successfully standardized and validated, being able to quantify all types of samples (blood and organs), in the acute, subacute and chronic phases of the disease, signaling positively to the use of both molecular assays in the diagnosis of T. cruzi infections.

No description available.